Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A **combination drug** containing **dexamethasone**, a synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive effects, and **various vitamins** (most commonly B vitamins such as B1, B6, and B12, but could vary depending on the specific product or regional formulation). The combination is used to treat conditions where both anti-inflammatory action and nutritional nerve support are indicated, such as certain neuropathic pain syndromes. Dexamethasone downregulates immune and inflammatory processes through glucocorticoid receptor agonism, while vitamins—often involving B1 (thiamine), B6 (pyridoxine), and B12 (cobalamin)—play a role in nerve metabolism and repair. Typically, these combination formulations are administered orally and aim to alleviate symptoms and foster nerve regeneration or protection, particularly in neuropathic conditions[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dexamethasone + vitamins.